Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Avadel Pharmaceuticals plc (AVDL) will participate in a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 14. The live webcast and archived recording will be available on Avadel's Investor Relations website for 90 days.
02/07/2024 - 08:00 AM
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Wednesday, February 14 at 2:00 p.m. ET.
A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com , for 90 days following the conference.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZTM , was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com .
Investor Contact:
Media Contact:
When will Avadel Pharmaceuticals participate in the fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference?
Avadel Pharmaceuticals will participate in the fireside chat on February 14 at 2:00 p.m. ET.
Where can I watch the live webcast of the fireside chat?
The live webcast will be available on Avadel's Investor Relations website, investors.avadel.com.
For how long will the archived recording of the fireside chat be available?
The archived recording will be available for 90 days following the conference on Avadel's Investor Relations website.
Avadel Pharmaceuticals plc
AVDL Rankings
#397 Ranked by Stock Gains
AVDL Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Medicinal and Botanical Manufacturing
Country
Ireland
City
Dublin
About AVDL
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
